Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Barbara Troupin currently holds 70,000 shares of APRICUS BIOSCIENCES, INC. (APRI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Barbara Troupin has been a net neutral trader of APRI stock. They have purchased $0 and sold $0 worth of shares.
Barbara Troupin's most recent insider trade was on May 28, 2026, when they sold 70,000 shares at $0.00 per share.
Barbara Troupin serves as Executive at APRICUS BIOSCIENCES, INC. (APRI). They have executed 3 insider transactions totaling $0 over their tenure at the company.
Barbara Troupin holds the position of Executive at APRICUS BIOSCIENCES, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Barbara Troupin has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Barbara Troupin was on May 28, 2026, when they purchased $0 worth of EQ shares. This transaction involved 70,000 shares at N/A per share.
Barbara Troupin currently owns 70,000 shares of APRICUS BIOSCIENCES, INC. (APRI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Barbara Troupin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Barbara Troupin has 3 Form 4 filings on record as an insider at APRICUS BIOSCIENCES, INC..
Set alerts for Barbara Troupin and 40,000+ other insiders.